London – Positive high-level results from an interim analysis of the AMPLIFY Phase III trial showed a fixed duration of AstraZeneca’s Calquence (acalabrutinib) in combination with venetoclax, with or without obinutuzumab, demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard-of-care chemoimmunotherapy in previously untreated adult patients with chronic lymphocytic leukaemia (CLL). For the secondary …
Boston- Those who drank a glass or more of 100% fruit juice every day showed minor rise in weight, a study revealed. Co-author and leading nutrition researcher Dr Walter Willett, a professor of epidemiology and nutrition at Harvard TH Chan School of Public Health and professor of medicine at Harvard Medical School in Boston, said: “One fundamental problem with juice is …
Washington – A recent study published in the journal Jama Network Open has presented key data that individuals making daily beverage choices, can affect liver health. After two decades of research, Harvard Medical School scientists have found our that consumption of sweetened beverages poses a significant threat of increased liver cancer in postmenopausal women. Liver cancer rates for women consuming sweetened …
